Sponsors

Phase III COPD Case Study: 85% of patients were diverse

When planning their trial, a sponsor faced two key challenges: reaching engaged community sites and improving patient diversity. To overcome these challenges and achieve their enrollment goals, they partnered with Inato to connect with high-performing sites that could drive both reach and representation.

Recommended

Sponsors

Phase III Atopic Dermatitis: 123% of Inato's patient enrollment achieved

Sponsors

Phase III CVD: 115% of Inato's patient enrollment achieved

Sponsors

Asthma Case Study: 181% of Inato’s patient enrollment achieved

Sponsors

Oncology Case Study: 66% faster enrollment time